The Associate Vice President, Aging, owns Lilly’s aging strategy within Mobility and Healthy Aging (MHA), a pillar of Cardiometabolic Research (CMR), and serves as its senior scientific voice internally and externally. The leader brings deep expertise in the biology of aging—including cellular senescence, proteostasis, mitochondrial dysfunction, chronic inflammation, and epigenetic and molecular measures of biological age—to decisions about mechanisms, patient populations and settings, organizational capabilities, and portfolio fit. The role is accountable for the scientific credibility of aging-directed targets and assets in the MHA portfolio, and for translating aging biology into medicines with definable patient populations and measurable endpoints. The leader works across bone, muscle, and joint biology to identify interventions that address aging biology while delivering functional benefits across tissues, and collaborates with scientists and leaders across Lilly on new approaches to aging and age-related disorders. The position leads aging science, strategy, and portfolio decisions; advises on biomarkers, models, assays, and translational tools; builds scientific capabilities and teams; represents Lilly in the aging research community; and supports external opportunities and collaborations. Up to 25% US/global travel is required.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Executive
Education Level
Ph.D. or professional degree